BALYASNY ASSET MANAGEMENT L.P. - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 191 filers reported holding GENMAB A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$936,489
+224.7%
26,552
+249.9%
0.00%
+100.0%
Q2 2023$288,458
-72.8%
7,589
-69.7%
0.00%
-66.7%
Q4 2022$1,059,754
-34.6%
25,006
-50.4%
0.00%
-40.0%
Q3 2022$1,620,000
+203.4%
50,419
+245.5%
0.01%
+25.0%
Q3 2020$534,000
+8.8%
14,591
-37.1%
0.00%
-33.3%
Q1 2020$491,000
-46.0%
23,179
-43.0%
0.01%
+20.0%
Q4 2019$909,00040,6990.01%
Other shareholders
GENMAB A/S shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 52,148$1,839,2601.67%
Ativo Capital Management LLC 28,442$1,003,1321.13%
HARDING LOEVNER LP 3,204,230$113,013,1830.75%
Hardman Johnston Global Advisors LLC 592,318$20,891,0560.70%
Yorktown Management & Research Co Inc 16,600$585,4820.66%
TORRAY INVESTMENT PARTNERS LLC 104,516$3,686,2790.65%
First Light Asset Management, LLC 157,147$5,542,5750.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 44,300$1,561,5750.53%
Capricorn Fund Managers Ltd 37,007$1,305,2370.45%
Legacy Wealth Asset Management, LLC 29,496$1,040,3240.38%
View complete list of GENMAB A/S shareholders